TrialAlzheimer's research & therapy2023

Cognitive impact of multidomain intervention and omega 3 according to blood Aβ42/40 ratio: a subgroup analysis from the randomized MAPT trial.

Julien Delrieu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.